Gene expression analysis revealed an interaction between sonidegib and 177Lu-octreotate, affecting several cancer-related signaling pathways (i.e. Wnt/β-catenin, PI3K/AKT/mTOR, G-protein coupled receptor, and Notch) not affected by either monotherapy. The gene discussed is ACKR3; the disease is cancer.